Luteolin: A Potential Multiple Targeted Drug Effectively Inhibits Diabetes Mellitus Protein Targets
- 22 September 2021
- journal article
- research article
- Published by Sciencedomain International in Journal of Pharmaceutical Research International
- Vol. 33 (44B), 161-171
- https://doi.org/10.9734/jpri/2021/v33i44b32661
Abstract
Background: Diabetes is a significant health problem that has reached worrisome proportions: almost half of the world's population now has diabetes. Diabetes mellitus, or diabetes, is a severe, long-term disease in which a person's blood glucose levels are elevated due to their body's inability to make any or enough insulin, or to properly utilise the insulin that it does produce. The chemicals extracted from medicinal plants were shown to be both safer and more bioactive than manufactured medicines. Objective: The goal of this research was to use molecular docking to find possible binding affinities of luteolin, a phytocompound from Rumex vesicarius L, to five target proteins, in order to find the lead molecule against diabetes. Methodology: One chemical was isolated from Rumex vesicarius L. leaves in this research. The binding affinity of the complexes was calculated using molecular docking studies. The docking procedure was carried out using AutoDock Tools 1.5.6, which brought the ligand together with the target proteins. Results: The binding energies of Luteolin with major Glutamine-fructose-6-phosphate amido transferase (GFAT1), Pancreatic α-Amylase, Forkhead box protein O1(FOX01), α--glucosidase, and Dipeptidyl peptidase-4 (DPP-4) were determined to be -6.89, -6.80, -6.36, -9.35, and -7.72 kcal. Conclusion: Our findings suggest that luteolin can target not only α--glucosidase but also DPP4 and other targets, suggesting that they may be used as type 2 diabetes mellitus inhibitors. We believe that this phytochemical, luteolin, may be utilised in preclinical studies as an anti-diabetic drug to combat diabetes mellitus.Keywords
This publication has 19 references indexed in Scilit:
- Traditional Indian Medicines Used for the Management of Diabetes MellitusJournal of Diabetes Research, 2013
- The Evaluation of Serum Amylase in the Patients of Type 2 Diabetes Mellitus, with a Possible Correlation with the Pancreatic FunctionsJournal of Clinical and Diagnostic Research, 2013
- Preclinical evaluation of hypoglycemic activity of Ipomoea digitata tuber in streptozotocin-induced diabetic ratsJournal of Basic and Clinical Physiology and Pharmacology, 2012
- Anti-hyperglycemic activity of the leaves of Tetracera scandens Linn. Merr. (Dilleniaceae) in alloxan induced diabetic ratsJournal of Ethnopharmacology, 2010
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- The role of FoxO in the regulation of metabolismOncogene, 2008
- DPP-4 inhibitor therapy: new directions in the treatment of type 2 diabetesFrontiers in Bioscience-Landmark, 2008
- Dynamic FoxO transcription factorsJournal of Cell Science, 2007
- Glucose Regulates Foxo1 Through Insulin Receptor Signaling in the Pancreatic Islet β-cellDiabetes, 2006
- Molecular Therapeutic Target for Type-2 DiabetesJournal of Proteome Research, 2004